Conn’s Current Therapy 2017, 1e
by Edward T. Bope MD, Rick D. Kellerman MD
- Hardcover: 1408 pages
- Publisher: Elsevier; 1 edition (December 27, 2016)
- Language: English
- ISBN-10: 0323443206
- ISBN-13: 978-0323443203
- Amazon Price: $89.99
- Points to download: 90 Points
- Format: Original Publisher PDF
- File Size: 54.6 MB
- Download link below.
This post contains protected content. You must be logged in and have 90 points to unlock it.
Covering more than 300 clinically relevant topics, Conn’s Current Therapy 2017 by Drs. Edward T. Bope and Rick D. Kellerman offers an in-depth, personal approach to treatment from international experts, ideally suited for today’s busy medical practitioners. Trustworthy and easy to use, this annually updated resource focuses solely on the most current treatment protocols for common complaints, acute diseases, and chronic illnesses you’re likely to see. New chapters and numerous new authors in this edition bring you fully up to date on the topics you need to know about for effective patient care.Reliable, in-depth, systems-based content suitable for all first-line-of-defense providers. Thorough PharmD review of recently approved and soon-to-be approved drugs. Easy access to the latest evidence-based treatment practices for the most effective results. More than 400 easy-to-understand tables make referencing complex data quick and easy. Nearly 300 images, including algorithms, anatomical illustrations, and photographs, provide useful information for diagnosis.
Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.
Easy access to the latest evidence-based treatment practices for the most effective results.
Seven new chapters cover palliative care, pancreatic cancer, babesiosis, Zika virus, sexual dysfunction, bronchiolitis, and failure to thrive. New authors provide a fresh perspective and their personal approach to scores of conditions and topics, including arboviruses and other emerging viruses.